OnKure Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
OnKure Therapeutics Operating Expenses Growth & History (OKUR)
OnKure Therapeutics's operating expenses was $63.0M for fiscal 2025.
View full OnKure Therapeutics company overviewOnKure Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $63.0M | $8.6M | +15.75% |
| 2024 | 2024-12-31 | $54.4M | $17.5M | +47.25% |
| 2023 | 2023-12-31 | $36.9M | −$16.9M | −31.41% |
| 2022 | 2022-12-31 | $53.8M | $14.0M | +35.24% |
| 2021 | 2021-12-31 | $39.8M | $20.3M | +103.65% |
| 2020 | 2020-12-31 | $19.6M | — | — |
OnKure Therapeutics quarterly operating expenses
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16.9M | $575,000 | +3.52% |
| Q1 2026 | 2026-03-31 | $15.6M | −$1.4M | −8.15% |
| Q4 2025 | 2025-12-31 | $14.1M | −$4.6M | −24.47% |
| Q3 2025 | 2025-09-30 | $15.5M | $4.0M | +34.65% |
| Q2 2025 | 2025-06-30 | $16.3M | $2.0M | +13.81% |
| Q1 2025 | 2025-03-31 | $17.0M | $7.2M | +72.92% |
| Q4 2024 | 2024-12-31 | $18.7M | — | — |
| Q3 2024 | 2024-09-30 | $11.5M | −$9.4M | −44.89% |
| Q2 2024 | 2024-06-30 | $14.3M | −$6.7M | −31.83% |
| Q1 2024 | 2024-03-31 | $9.8M | −$6.3M | −39.02% |
| Q3 2023 | 2023-09-30 | $20.9M | $7.0M | +50.92% |
| Q2 2023 | 2023-06-30 | $21.0M | $8.6M | +69.25% |
| Q1 2023 | 2023-03-31 | $16.1M | $3.1M | +23.88% |
| Q4 2022 | 2022-12-31 | $14.6M | $3.9M | +37.07% |
| Q3 2022 | 2022-09-30 | $13.8M | $1.1M | +8.53% |
| Q2 2022 | 2022-06-30 | $12.4M | $3.2M | +34.71% |
| Q1 2022 | 2022-03-31 | $13.0M | $5.8M | +80.41% |
| Q4 2021 | 2021-12-31 | $10.6M | $4.4M | +69.93% |
| Q3 2021 | 2021-09-30 | $12.8M | $7.7M | +150.09% |
| Q2 2021 | 2021-06-30 | $9.2M | $5.5M | +149.47% |
| Q1 2021 | 2021-03-31 | $7.2M | $2.7M | +60.24% |
| Q4 2020 | 2020-12-31 | $6.3M | — | — |
| Q3 2020 | 2020-09-30 | $5.1M | — | — |
| Q2 2020 | 2020-06-30 | $3.7M | — | — |
| Q1 2020 | 2020-03-31 | $4.5M | — | — |
OnKure Therapeutics operating expenses trends
Over the last five fiscal years, OnKure Therapeutics's operating expenses increased from $19.6M to $63.0M, a change of $43.4M. The latest reported quarter, Q2 2026, shows $16.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OnKure Therapeutics source filings ↗